• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要组织相容性复合体I类链相关蛋白A和B(MICA和MICB)主要在肿瘤组织和正常组织的细胞内表达。

MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue.

作者信息

Ghadially Hormas, Brown Lee, Lloyd Chris, Lewis Leeanne, Lewis Arthur, Dillon Janette, Sainson Richard, Jovanovic Jelena, Tigue Natalie J, Bannister David, Bamber Lisa, Valge-Archer Viia, Wilkinson Robert W

机构信息

MedImmune Ltd., Granta Park, Cambridge CB21 6GH, UK.

AstraZeneca, Chesterford Research Park, Little Chesterford CB10 1XL, UK.

出版信息

Br J Cancer. 2017 Apr 25;116(9):1208-1217. doi: 10.1038/bjc.2017.79. Epub 2017 Mar 23.

DOI:10.1038/bjc.2017.79
PMID:28334733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5418453/
Abstract

BACKGROUND

Major histocompatibility complex (MHC) class I chain-related protein A (MICA) and MHC class I chain-related protein B (MICB) are polymorphic proteins that are induced upon stress, damage or transformation of cells which act as a 'kill me' signal through the natural-killer group 2, member D receptor expressed on cytotoxic lymphocytes. MICA/B are not thought to be constitutively expressed by healthy normal cells but expression has been reported for most tumour types. However, it is not clear how much of this protein is expressed on the cell surface.

METHODS

Using a novel, well-characterised antibody and both standard and confocal microscopy, we systematically profiled MICA/B expression in multiple human tumour and normal tissue.

RESULTS

High expression of MICA/B was detected in the majority of tumour tissues from multiple indications. Importantly, MICA/B proteins were predominantly localised intracellularly with only occasional evidence of cell membrane localisation. MICA/B expression was also demonstrated in most normal tissue epithelia and predominantly localised intracellularly. Crucially, we did not observe qualitative differences in cell surface expression between tumour and MICA/B expressing normal epithelia.

CONCLUSIONS

This demonstrates for the first time that MICA/B is more broadly expressed in normal tissue and that expression is mainly intracellular with only a small fraction appearing on the cell surface of some epithelia and tumour cells.

摘要

背景

主要组织相容性复合体(MHC)I类链相关蛋白A(MICA)和MHC I类链相关蛋白B(MICB)是多态性蛋白,在细胞受到应激、损伤或转化时被诱导产生,它们通过细胞毒性淋巴细胞上表达的自然杀伤细胞2成员D受体作为“杀死我”信号发挥作用。MICA/B被认为不是健康正常细胞组成性表达的蛋白,但已报道在大多数肿瘤类型中存在表达。然而,尚不清楚这种蛋白在细胞表面的表达量。

方法

使用一种新型的、特性明确的抗体以及标准显微镜和共聚焦显微镜,我们系统地分析了MICA/B在多种人类肿瘤和正常组织中的表达情况。

结果

在多种适应症的大多数肿瘤组织中检测到MICA/B的高表达。重要的是,MICA/B蛋白主要定位于细胞内,仅有偶尔的细胞膜定位证据。在大多数正常组织上皮中也证实了MICA/B的表达,且主要定位于细胞内。关键的是,我们未观察到肿瘤与表达MICA/B的正常上皮细胞在细胞表面表达上的质的差异。

结论

这首次证明MICA/B在正常组织中更广泛表达,且表达主要在细胞内,只有一小部分出现在某些上皮细胞和肿瘤细胞的细胞表面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/6b0c73431dd5/bjc201779f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/880cf1680f43/bjc201779f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/d5c3220ba4a7/bjc201779f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/f0cc4b20ed58/bjc201779f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/6b0c73431dd5/bjc201779f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/880cf1680f43/bjc201779f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/d5c3220ba4a7/bjc201779f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/f0cc4b20ed58/bjc201779f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d48/5418453/6b0c73431dd5/bjc201779f4.jpg

相似文献

1
MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue.主要组织相容性复合体I类链相关蛋白A和B(MICA和MICB)主要在肿瘤组织和正常组织的细胞内表达。
Br J Cancer. 2017 Apr 25;116(9):1208-1217. doi: 10.1038/bjc.2017.79. Epub 2017 Mar 23.
2
HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.HER2/HER3 信号通过人乳腺癌细胞系中 MHC Ⅰ类链相关分子 A 和 B 的表达调节 NK 细胞介导的细胞毒性。
J Immunol. 2012 Mar 1;188(5):2136-45. doi: 10.4049/jimmunol.1102237. Epub 2012 Feb 1.
3
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.不同人类肿瘤细胞系中内源性 MHC Ⅰ类相关链分子 A 和 B 的脱落:“解整合素和金属蛋白酶”10 和 17 的异质性参与。
Int J Cancer. 2013 Oct 1;133(7):1557-66. doi: 10.1002/ijc.28174. Epub 2013 Apr 18.
4
Diversity and characterization of polymorphic 5' promoter haplotypes of MICA and MICB genes.MICA和MICB基因多态性5'启动子单倍型的多样性与特征分析
Tissue Antigens. 2014 Sep;84(3):293-303. doi: 10.1111/tan.12400. Epub 2014 Jun 25.
5
NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.NZ28诱导的HSF1、SP1和NF-κB抑制引发人肿瘤细胞上自然杀伤细胞激活配体MICA/B的丧失。
Cancer Immunol Immunother. 2015 May;64(5):599-608. doi: 10.1007/s00262-015-1665-9. Epub 2015 Feb 18.
6
Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients.主要组织相容性复合体I类相关链A和B(MICA/B)在胃癌患者肿瘤中的表达的临床意义
Oncol Rep. 2016 Mar;35(3):1309-17. doi: 10.3892/or.2015.4510. Epub 2015 Dec 23.
7
Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer.主要组织相容性复合体I类相关链A和B在甲状腺癌中的表达的临床病理意义
J Clin Endocrinol Metab. 2006 Jul;91(7):2704-12. doi: 10.1210/jc.2006-0492. Epub 2006 Apr 18.
8
Expression of major histocompatibility complex class I-related chain A/B (MICA/B) in pancreatic carcinoma.主要组织相容性复合体Ⅰ类相关链 A/B(MICA/B)在胰腺癌中的表达。
Int J Oncol. 2014 Jan;44(1):99-104. doi: 10.3892/ijo.2013.2156. Epub 2013 Oct 31.
9
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.MICA和MICB在人类肝细胞癌中的表达、作用及其受视黄酸的调控
Int J Cancer. 2003 Apr 10;104(3):354-61. doi: 10.1002/ijc.10966.
10
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.不同组织类型肿瘤细胞系上主要组织相容性复合体I类相关链A和UL16结合蛋白的表达:肿瘤对NKG2D依赖性自然杀伤细胞细胞毒性的易感性分析
Cancer Res. 2002 Nov 1;62(21):6178-86.

引用本文的文献

1
HLA Class Ib and MICA/MICB Expression in Human Tissues and Cell Types: Reshuffling Immune Players.人类组织和细胞类型中的HLA Ib类分子以及MICA/MICB表达:重新排列免疫参与者
HLA. 2025 Sep;106(3):e70390. doi: 10.1111/tan.70390.
2
Model Systems of Gammaherpesvirus Infection, Immunity, and Disease.γ疱疹病毒感染、免疫与疾病的模型系统
J Med Virol. 2025 Sep;97(9):e70581. doi: 10.1002/jmv.70581.
3
Chemotherapy-induced alterations in miRNA expression and their prognostic implications in ovarian cancer.化疗引起的微小RNA表达改变及其在卵巢癌中的预后意义。

本文引用的文献

1
Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients.主要组织相容性复合体I类相关链A和B(MICA/B)在胃癌患者肿瘤中的表达的临床意义
Oncol Rep. 2016 Mar;35(3):1309-17. doi: 10.3892/or.2015.4510. Epub 2015 Dec 23.
2
NKG2D Ligands in Tumor Immunity: Two Sides of a Coin.肿瘤免疫中的NKG2D配体:硬币的两面
Front Immunol. 2015 Mar 4;6:97. doi: 10.3389/fimmu.2015.00097. eCollection 2015.
3
Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope "tags".
Front Oncol. 2025 Aug 22;15:1580565. doi: 10.3389/fonc.2025.1580565. eCollection 2025.
4
Methodological approach for allele-specific antibody responses to HEK-293T-based cell lines expressing single MHC class I chain-related gene B antigens.针对表达单个MHC I类链相关基因B抗原的基于人胚肾293T细胞系的等位基因特异性抗体反应的方法学。
BMC Mol Cell Biol. 2025 Jul 16;26(1):22. doi: 10.1186/s12860-025-00549-5.
5
Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for osteomyelitis.利用人类血浆蛋白质组进行全蛋白质组范围的系统孟德尔随机化,以确定骨髓炎的治疗靶点。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 14. doi: 10.1007/s00210-025-04429-9.
6
CLN-619, a MICA/B monoclonal antibody that promotes innate immune cell-mediated antitumor activity.CLN-619,一种促进先天免疫细胞介导的抗肿瘤活性的MICA/B单克隆抗体。
J Immunother Cancer. 2025 Apr 23;13(4):e008987. doi: 10.1136/jitc-2024-008987.
7
Genetically druggable targets for MAPK-activated colorectal cancer by a two-sample mendelian randomization analysis.通过两样本孟德尔随机化分析确定的MAPK激活型结直肠癌的基因可靶向治疗靶点
Sci Rep. 2025 Apr 10;15(1):12239. doi: 10.1038/s41598-024-82567-5.
8
An epitope-directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA/B α1/2 shedding.一种表位导向的mRNA疫苗通过阻断MICA/B α1/2脱落来抑制肿瘤转移。
Cell Rep Med. 2025 Mar 18;6(3):101981. doi: 10.1016/j.xcrm.2025.101981. Epub 2025 Feb 24.
9
Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors.免疫检查点抑制剂难治性肺癌的工程化自然杀伤细胞试验中期报告。
JCI Insight. 2025 Feb 4;10(6):e186890. doi: 10.1172/jci.insight.186890.
10
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives.神经母细胞瘤中的自然杀伤细胞:免疫见解和治疗观点。
Cancer Metastasis Rev. 2024 Dec;43(4):1401-1417. doi: 10.1007/s10555-024-10212-8. Epub 2024 Sep 18.
利用T细胞表位“标签”生成针对自身蛋白的强效小鼠单克隆抗体。
MAbs. 2015;7(1):129-37. doi: 10.4161/19420862.2014.985489.
4
Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.等位基因频率网络2015年更新:HLA表位、杀伤细胞免疫球蛋白样受体以及疾病与HLA药物不良反应关联的新特征
Nucleic Acids Res. 2015 Jan;43(Database issue):D784-8. doi: 10.1093/nar/gku1166. Epub 2014 Nov 20.
5
A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells.肿瘤细胞膜上由缺氧诱导的MICA/B或Hsp70减少介导了对自然杀伤细胞的免疫逃逸。
Cell Stress Chaperones. 2015 Jan;20(1):139-47. doi: 10.1007/s12192-014-0532-5. Epub 2014 Aug 8.
6
N-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24.天冬酰胺8的N-糖基化调节主要组织相容性复合体I类链相关蛋白A(MICA)等位基因的表面表达,该表达依赖于苏氨酸24。
J Biol Chem. 2014 Jul 18;289(29):20078-91. doi: 10.1074/jbc.M114.573238. Epub 2014 May 28.
7
Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical based histopathology researchers.用于生物标志物发现的免疫组织化学抗体验证:一个由学术和制药领域的组织病理学研究人员组成的联盟的建议
Methods. 2014 Nov;70(1):34-8. doi: 10.1016/j.ymeth.2014.01.018. Epub 2014 Feb 11.
8
New prospects on the NKG2D/NKG2DL system for oncology.NKG2D/NKG2DL系统在肿瘤学领域的新前景。
Oncoimmunology. 2013 Oct 1;2(10):e26097. doi: 10.4161/onci.26097. Epub 2013 Oct 25.
9
Broad MICA/B expression in the small bowel mucosa: a link between cellular stress and celiac disease.小肠黏膜中广泛的 MIC A/B 表达:细胞应激与乳糜泻之间的联系。
PLoS One. 2013 Sep 13;8(9):e73658. doi: 10.1371/journal.pone.0073658. eCollection 2013.
10
NKG2D ligands as therapeutic targets.NKG2D配体作为治疗靶点。
Cancer Immun. 2013 May 1;13:8. Print 2013.